Get help from the best in academic writing.

MKT 500 Strayer University Above Average Fitness Company Marketing Plan Essay

MKT 500 Strayer University Above Average Fitness Company Marketing Plan Essay.

I’m working on a business writing question and need an explanation to help me understand better.

PART B: YOUR MARKETING PLANPart B: Your Marketing PlanOverviewUsing the same hypothetical company from Part A: Your Marketing Plan, for this assignment, you will focus on the company’s branding strategy, primary and secondary target markets, positioning statement, and consumer behavior.Note: You should make all assumptions needed for the completion of this assignment.InstructionsCreate the second part of your marketing plan in 8–12 pages:Describe or list the feedback you received on Part A of your marketing plan. Explain how you will use the feedback to improve your plan.Develop a branding strategy for your product or service that covers the brand name, logo, slogan, and at least one brand extension.Thoroughly analyze the primary and secondary markets that you want to target. Thoroughly include the demographic profile (age, gender, ethnicity, and so on), psychographic profile, professional profile, geographic profile, and any other segment you deem necessary.Prepare a positioning statement. Include a perceptual map that shows your company’s position against its competitors. From this map, create a statement that depicts your position.Examine the relevant consumer behavior for your target market. Explain the main reasons why the brand name, logo, slogan, brand extension, and positioning statement are right for the identified target market.Use at least three academic resources as quantitative marketing research to determine the feasibility of your product or service. These resources should be industry specific and relate to your chosen product or service.Use the Part B Marketing Plan Template [DOCX] to complete the assignment.Note: Wikipedia and other similar websites do not qualify as academic resources.This course requires the use of Strayer Writing Standards. For assistance and information, please refer to the Strayer Writing Standards link in the left-hand menu of your course. Check with your professor for any additional instructions.The specific course learning outcomes associated with this assignment are:Develop a branding strategy for a target market based on relevant consumer behavior.
MKT 500 Strayer University Above Average Fitness Company Marketing Plan Essay

Pocast review. Paper details List the main concepts discussed in the podcast episode. How do they tie to (supplement or complement) the concepts presented in this course? What are the questions that are most intriguing to you in this podcast? Why? What are the key research findings that are presented? How do those concepts apply to your world of work, career, and personal growth? What are other questions you wish were asked in this podcast but were not? Here is the podcast review
UCR Mental Health Careers & Intellectual Disabilities Annotated Bibliography.

Assignment #3:DISABILITY CURRENT AFFAIRS: COVID-19 10 pointsBackground: There is great discussion and distress around the subject of societal responses to Covid-19 as it relates to people with disabilities. Whether it be people with medical disabilities/pre-existing conditions, or people with a mental health, developmental, intellectual, or sensory disabilities, the experience of quarantine, social distancing, and the question of receiving medical or other assistance, are daunting for many people with disabilities and their loved-ones. However, most nondisabled people remain unaware of the implications of the Coronavirus to the disability community. For this assignment, your task is to examine and learn how the Covid-19 pandemic is impacting this population. Learning Objectives: Students will summarize three references that address the topic of the Covid-19 Pandemic and the disability community. Students will apply their knowledge of course concepts to the Covid-10 Pandemic.Students will examine the controversies surrounding disability and Covid-19 and evaluate their own perspectives on these issues.Assignment Content RequirementsYou are required to summarize three references on this subject. These references can be a combination of peer-reviewed articles, online sources, or online videos. In your summaries, include the information to the reference, who the audience is for that reference, the purpose of their message, key points, and arguments. Consider the issues and arguments listed in the references you have explored. What three concepts discussed in class so far, presented themselves in your references? Elaborate on how they correlate with your findings. Contemplate the media exposure of Covid-19 and how it relates to people with disabilities. Is disability representation present in dominant media platforms? Do the perspectives you have read about or listened to permeate your social media feeds? Or is the new information surprising to you? What issues do you feel are most controversial at the intersection of Covid-19 and disability? Defend your argument.Assignment Format RequirementsMicrosoft Word ONLY12-point fontDouble-spaced2-page minimumAssignment #3 RubricCriteriaMeets Standard(10 pts)Approaching Standard(9-5 pts)Below Standard(0-4 pts)
Assignment ContentAssignment includes 3 references and responses to all prompts. Assignment is missing one or two required parts. Assignment is missing more than two required parts. Thoughtful Responses toEach SectionResponses demonstrate clear understanding of the questions/prompts. Responses are thoughtful, cohesive, descriptive, and complete. Responses demonstrate partial understanding of the questions/prompts, and/or responses are incomplete. Responses do not demonstrate understanding of the questions/prompts, and/or minimal effort is evident. WrittenExpressionWriting flows and is easy to comprehend and grade. Uses appropriate grammar and punctuation to clearly express thoughts.Writing includes some errors in grammar and/or punctuation, or is lacking in clear expression, but it is comprehensible enough that the reader can understand. Writing has many errors in grammar and/or punctuation and is confusing or difficult to understand. Disability Related Language Assignment utilizes appropriate disability related language. Uses person-first language unless the student is a person with a disability (PWD) and indicates identity-first language preference). Assignment avoids the use of inspiration porn or outdated, inappropriate disability-related euphemisms or terms. Wording affirms dignity.Assignment mostly utilizes appropriate disability related language. Mostly uses person-first language (unless identity-first language preferred by PWD). Assignment includes minimal inspiration porn or outdated, inappropriate disability-related euphemisms or terms. Wording may not always affirm dignity.Assignment uses inappropriate disability-related terminology, including inspiration porn, euphemisms, and terms that affronts the dignity of people with disabilities.
UCR Mental Health Careers & Intellectual Disabilities Annotated Bibliography

DISCUSS HOW LAW IS RELEVANT TO BUSINESS USING YOUR TEXT AND THE INTERNET TO: Identify and discuss at least two fundamental concepts and principles of the American legal system, particularly those pertaining to today’s business environment. Define ethics and evaluate how the law you have read in the first 2 chapters is based on ethical principles. Do you feel that corporate ethics, by and large, have worsened in recent years, or is it that these “bad guys” are made more visible by the media. Or is it the magnitude of the ethics violations. Thoughts class as it applies to what you think of ethics and business? REQUIREMENTS: Your original post should be a minimum of 300 words and based on your own unique composition. Read, evaluate and compose a substantial in-depth response (minimum 150 words) to at least one or more of your peer’s responses in the discussion area. See discussion rubric for grading details. Include examples in your discussion. Adhere to APA standards and use APA guidelines to cite references. Correct grammar, spelling, and punctuation are expected. Do not copy and paste someone else’s work.

Read the following excerpt from the MOCA exhibit written to introduce the concept of經絡jing luo:

Read the following excerpt from the MOCA exhibit written to introduce the concept of經絡jing luo:. Can you help me understand this Philosophy question?

In addition to the skeletal, circulatory, nervous and endocrine systems, Chinese medicine acknowledges the existence of the 經絡jing luo or meridian system through which qi and blood circulate throughout the body. The word “meridian” used in English language references of Chinese medicine comes from a 14th century French translation. Often we see the term ‘channel’ used interchangeably with ‘meridian.’. ‘Channel’ captures the idea of a conduit through which vital substances flow; while ‘meridian’ implies a longitudinal and latitudinal grid that encircles the globe and reminds us to think about our bodily connections on a macro level. Both are good descriptors of this system.
Consider the issue of language and the translation of language, and our particular reliance in the context of learning and practicing Chinese medicine in today’s cross cultural context; transmission through language written and spoken. What does language allow us to access and convey, where might there be hindrances? How do you, how can you account for this, work with it, manage this? Consider both your learning and scholarship, as well as in your practice (with patients, intra-professional, inter-professional, in the encounter with those who are like minded, those who are skeptical, others with whom there is little to no apparent resonance, etc).
Read the following excerpt from the MOCA exhibit written to introduce the concept of經絡jing luo:

Strategic management report

assignment writer Strategic management report. 1.0 Introduction I choose Genting Berhad as the organization for the Strategic Management report. I worked in Awana Genting Highlands almost one year before I worked in government sector. Awana Genting Highlands is one of the six hotels under the Genting Berhad. Genting Berhad is a management company and investment holding of Genting Group. It was founded by the late Tan Sri Lim Goh Tong in 1965 when he want to make a 20 km access road across mountainous which was located about 2000-metres above level sea. Tan Sri Lim Kok Thay is now the Chairman and Chief Executive of Genting Berhad. Genting Berhad is a Malaysian company with interests in a variety of fields. The group comprises of more than 15,000 employees, 11,000 acres of resort land and 156,000 acres of choice plantation land throughout Malaysia. The company is principally an investment holding and management company with seven major business divisions, such as leisureStrategic management report

Goals of Information Security in Organizations

Internet Security Systems Abstract In this paper, I discuss the answers to the following questions: What is the goal of information security within an organization? What is the difference between a threat, vulnerability, and a risk? What is more important for cybersecurity professionals to focus on: threats or vulnerabilities? What are your first three steps when securing a server? Do you prefer filtered ports or closed ports on your firewall? These questions allow us to think about the main factors internet security systems entail and raise awareness on prospective approaches to security systems. Information plays the primary role in various organizations as it entails the most data needed to keep systems secure. In order to maintain an effective security system, there are primarily three main goals of information security within an organization. These goals consist of confidentiality, integrity, and availability. Each goal addresses a different aspect of providing means of protection. Confidentiality involves maintaining privacy and secrecy during the transmission process of information, and most importantly from unauthorized users. In other words, only authorized users are given access to secret data within a security system. Failure to maintain confidentiality allows for unauthorized access and cannot be alleviated. Today, this is frequently seen in credit or debit card fraud where an individual’s bank account information cannot be erased from the scammer or internet once hacked. Therefore, a loss of confidentiality has occurred, showing how important it is to protect the means of confidentiality of data. Integrity refers to the validity of information. It only allows for changes to be made by authorized users and only through secure networks. Failure to preserve the integrity of data can lead to unauthorized access and intended changes presented by unauthorized users. Availability allows for information to be created and store for authorized users, otherwise information is unusable and worthless. Information must ensure availability for authorized users to access important information when needed. It is important to address these goals of information security within an organization to help prevent rival corporations from taking advantage of system operations and endorsing threats. In the article entitled, An Integrated System for Information Security Management with the Unified Framework,Yang, Ku, and Liu (2014) address the role of information security management when examining the security requirements needed to ensure a safe organization. The authors argue that security requirements are often neglected when considering support systems and propose what they call an integrated system for information security management (ISISM) to help solve the issue of neglect within systems. They believe that “the primary objective of the proposed ISISM is to develop a unified framework to handle processes of information security management” (Yang, Ku

Why Aspirin is Not Beneficial in Non-Diabetic Patients

Share this: Facebook Twitter Reddit LinkedIn WhatsApp Understanding the serious threat that cardiovascular disease poses and the various risk factors for developing this disease is fundamental to a patient’s health. Risks for cardiovascular disease can be due to a patient’s family history, gender, or age, but could also be indicative of their daily lifestyle. These factors can include hypertension, obesity, hyperlipidemia, unhealthy diet, and tobacco use. Prophylaxis with aspirin therapy or non-pharmacological treatment is a method in which patients can prevent adverse cardiovascular events, such as myocardial infarction or stroke.1 Aspirin is a cyclooxygenase-II inhibitor that acts on the coagulation cascade leading to decreased thrombin activity and decreased clot formation as a result. It can also work to reduce inflammation, fever, and pain. It is vital to use aspirin in the secondary prevention of cardiovascular disease because the patients are at such a high risk of additional events. However, an ongoing debate is whether primary prevention with aspirin is beneficial in non-diabetic patients. Determining when to prescribe aspirin is important to ensure consistent guidelines across the board and to maximize patients’ safety and overall health since cardiovascular disease is the number one cause of death in both men and women.2 Trials have been performed to determine whether aspirin is efficacious in certain patient populations, but no definite answer has been found in regards to primary prevention. The ARRIVE trial, the ASPREE trial, and lastly the Women’s Health study further explore the benefits and risks of using aspirin for primary prevention. From the primary literature, the use of aspirin in non-diabetic patients for the primary prevention of cardiovascular disease should not be given due to bleeding risks and increased death rates due to age. The Aspirin to Reduce Risk of Initial Vascular Events (ARRIVE) trial was a double-blind, randomized controlled trial that studied the efficacy of 100 mg enteric-coated aspirin daily compared to a placebo. It was a six-year study that followed 12,456 patients over a total of nine doctor’s visits.3 These patients, both men and women, were 55 years or older with 2 or more cardiovascular risk factors. These risk factors could include high blood pressure, high cholesterol, or a positive family history of cardiovascular disease. Most patients had an ASCVD risk score between 10-20%, which was indicative of their risk factors. However, patients were excluded if they had diabetes, high bleeding risks, history of a vascular event, or required antiplatelet therapy. The primary outcome was the time to cardiovascular death, myocardial infarction, stroke, unstable angina, or transient ischemic attacks.3 As mentioned above, the trial was a double-blind, randomized control trial, which decreases bias because neither patient nor researcher knows which medication the patient is receiving so results will not be skewed. Also, patients with diabetes were excluded from the study, which proved to strengthen this trial because diabetes itself is a major cardiovascular risk factor. By only studying non-diabetics we are able to see if aspirin can truly lower cardiovascular risks without the presence of a major factor. ARRIVE included women and older age individuals who were at risk of developing cardiovascular disease within this trial, which was a strength that separated them from other trials performed in the past. The trials also performed comprehensive analyses through intention-to-treat and per protocol testing. This allowed thorough testing and follow-up with patients from beginning to end to ensure the most accurate conclusions could be determined even if the patients did not complete the full duration of the study. The ARRIVE trial’s funding is considered a weakness since Bayer manufactures aspirin and funded this trial. The trial did not seem to find statistically significant differences between the aspirin group and placebo group, but how can one trust these results if Bayer was responsible for some portions of the study design, the data collection, analysis and interpretation? In addition, they also had an independent statistician and were responsible for the final decision on whether to publish the study or not. Would Bayer release study results that poorly demote their product, which would ultimately prompt questions of bias within this study and how accurate the conclusions truly are? At first, the data seemed to be promising and consistent. However, upon further investigation, the data was sporadic, which proved to be a weakness. At first glance, the Kaplan-Meier curves regarding the cumulative incidence of the primary outcome would lead one to believe the lines showed separation, meaning there were statistically significant differences between the two groups, which were in favor of aspirin. But, these curves were misleading in that each y-axis only increased by two percent intervals. Overall, the readers must ask themselves how applicable this data is based on the small intervals of the y-axis. In addition, the Forest plots were also inaccurate upon further interpretation. For example, the cardiovascular disease risk score quartiles show individuals with risk scores less than 21.6% favoring aspirin, while the group with a risk percent greater than 21.6% favoring the placebo.3 The overall confidence interval should be on the far side of the aspirin side, however it is very close to favoring placebo. Realistically, the individuals with a greater cardiovascular risk percent should favor aspirin if the lower percent did, but this was not the case. Therefore, this prompts the reader to inquire why there would be a disconnection between the data. Is the data skewed from inconsistencies in data collection and analyses or did Bayer skew the data to provide better results for themselves? Perhaps Bayer is trying to hide results about their product to prevent backlash or decrease in sales. Additionally, there were not enough events to reach the previous power wanted of 91%, so after receiving the data they had to adjust their protocol to adjust for a power of 80%.3 External validity is not strong with per-protocol population, but this population did show statistical significance regarding myocardial infarctions. The intention-to-treat population has a stronger external validity because patients will not always be compliant, but this population did not show a statistical difference. Which is more important? Overall, the ARRIVE trial determined aspirin is not an effective therapy in moderate risk patients for primary prevention of cardiovascular disease. Patients treated with aspirin had no reduction in the risk of cardiovascular incidences compared to the placebo. The aspirin treatment group also showed increased rates of gastrointestinal bleeding, 61 patients out of 6270 total, compared to the placebo group, 29 of the 6276 patients.3 Prescribing aspirin for primary prevention would only harm the patient due to bleeding risks with no benefits of reducing the risk of cardiovascular events. The trial’s funding bias and skewed data also further dispute the idea that aspirin should be given to individuals for primary prevention. The Aspirin Reducing Events in the Elderly (ASPREE) trial was a randomized, double-blind study that studied whether low dose aspirin could extend the life of healthy elderly individuals. Men and women who were 70 years or older and were compliant when taking pills due to a 1 month trial were included in this study.4 They could not have cardiovascular disease, dementia, high bleeding risks, anemia, disabilities, or were expected to die within 5 years. Exclusions included use of anticoagulants or antiplatelet therapy and blood pressure higher than 180/105 mmHg.4 Once they were eligible, the 19,114 participants were then randomized and received either aspirin 100 mg or placebo.4,5 The primary outcome for this trial was a composite of death, dementia, or persistent disability. The National Institute on Aging was the primary financial resource, which strengthens this study’s findings since it is a non-biased source as opposed to Bayer funding the ARRIVE trial. This study also set clear, distinct standards as to what they considered bleeding to be.4 This was a major strength and improved the study’s accuracy and results. The sample size in which this study drew results from was vast, which is another strength. Additionally, this study used intention-to-treat and Cox regression to analyze the data.4,5 The confidence intervals were not adjusted, thus concluding the data is accurate and raw, unlike the ARRIVE trial, furthering increasing the strength of this study. The National Institute on Aging stopped the trial early because the data already collected and analyzed proved there would be no benefit regarding the primary outcome in continuing treatment.5 Concerning major bleeding, the aspirin group showed significantly higher results compared to the placebo group and the risk of major hemorrhaging increased with continued use of aspirin (hazard ratio: 1.38, confidence interval: 1.18 to 1.62, p< 0.001).4 The study concluded that individuals who were over 70 years old should not take aspirin due to the high mortality rates and increased bleeding risks. In patients who received aspirin, there were 1.6 excess deaths per 1000 years after 4.7 years compared to the placebo.4,5 Previous trials have not found results similar to this statistic, thus one should question how accurate the results prove to be. The median age for the participants was 74 years old, which is considered a weakness and limitation. One of the risk factors for cardiovascular disease is age; therefore, only studying individuals who are already at risk of developing the disease could have skewed the data results. Out of the 19,114 participants, 1052 individuals died during the trial.5 Did the individuals die of natural causes or was it from the aspirin? To determine this and to eliminate bias, an outside adjudicator with no knowledge of which patient was in which group was responsible for determining the cause of death, which was considered a strength.5 Not only was the adjudicator an unbiased source, it also helped reduce limitation from the median age. Adherence was noted to be an issue towards the end of the trial, which could have skewed data results and weakened the trial’s conclusions. Was forgetfulness with age becoming an increasing problem for these individuals who were deemed prior to the study free of dementia or did they begin noticing adverse side effects and stop taking the medication? Despite its few weaknesses, the ASPREE trial proved to be a strong trial that discouraged the use of aspirin in the elderly for primary prevention due to increased bleeding risks and death rates. The Women’s Health Study was a two-by-two factorial, randomized control trial that compared the combination of aspirin and vitamin E to placebo in the primary prevention of cardiovascular disease in 39,876 healthy women.2 This study sought to determine the lowest dose of aspirin one could take to receive cardio-protective effects, while also reducing bleeding risks. Women who were 45 years or older were eligible if they had no history of cancer, cardiovascular disease, or another major illness. They could not be taking more than one dose of aspirin or vitamin supplements (A, E, or beta-carotene) per week. These women also could not be on any anticoagulants or corticosteroids. The women were followed for 10 years to assess for a combination primary endpoint of myocardial infarction, stroke, or death as a result of cardiovascular issues.2 These individuals took aspirin and vitamin E every other day. This could create complications with compliance because the patient has to remember what pills to take on what specific day, which could skew results. The Women’s Health Study not only received a grant from Bayer, but also received their drug supply from them. As with the ARRIVE trial, this causes major flaws and bias within the study data. How can one trust these results when the manufacturer is once again funding the study and supplying the drug? The greatest strength of this study was the fact they used only women. For example, while there’s no difference in myocardial infarction with aspirin, the big difference is in stroke. This is significant because women have more strokes than men.1 This can also emphasize how important it is to study different populations like gender when it comes to drug therapy. In addition, their population size was vast. This gave them the ability to have a high power to detect differences in subgroups. Cox regression and intention-to-treat analyses were performed for all primary endpoints, which helped to ensure accurate results. The Women’s Health Study showed that aspirin had more of an effect on the elderly population seeing as they had one third of the cardiovascular events. Bleeding in the aspirin group was statistically significant when compared to the placebo group (p = 0.02). The transient ischemic attack was also significant, as well as the overall stroke risk. Once again, this study proves aspirin causes more harm than benefit in the treatment of primary prevention of cardiovascular disease. After reviewing the three trials, it is obvious aspirin should not be used in the primary prevention of cardiovascular disease. Not only does it increase the risk of bleeding, but it also causes increased numbers of mortality. Additionally, it shows no risk in reducing the occurrence of cardiovascular events. Instead of having these patients take aspirin, which causes more harm than benefit, doctors should focus on having these individuals make lifestyle modifications to reduce their risk of developing cardiovascular disease. A healthy and nutritious diet with low salt intake and physical activity can significantly reduce one’s risk. In conclusion, prophylaxis with non-pharmacological treatments will provide the most benefit in patients compared to prophylaxis with aspirin in patients needing primary prevention for cardiovascular disease. References: Sergio Coccheri. Use and misuse of aspirin in primary cardiovascular prevention. Clinical Medicine Insights: Cardiology. 2017;2017(11):1179546817702149. doi: 10.1177/1179546817702149. Ridker PM, Cook NR, Lee I, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. The New England Journal of Medicine. 2005;352(13):1293-1304. doi: 10.1056/NEJMoa050613. Gaziano JM, Brotons C, Coppolecchia R, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): A randomised, double-blind, placebo-controlled trial. The Lancet. 2018;392(10152):1036-1046. McNeil JJ, Wolfe R, Woods RL, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. The New England Journal of Medicine. 2018;379(16):1509-1518. doi: 10.1056/NEJMoa1805819. McNeil JJ, Nelson MR, Woods RL, et al. Effect of aspirin on all-cause mortality in the healthy elderly. The New England Journal of Medicine. 2018;379(16):1519-1528. doi: 10.1056/NEJMoa1803955. Share this: Facebook Twitter Reddit LinkedIn WhatsApp